menu
search

    Jakafi

    A drug used to treat adults with certain types of primary myelofibrosis (MF), post-polycythemia vera MF, post-essential thrombocythemia MF, or polycythemia vera, and adults and children aged 12 years and older with acute or chronic graft-versus-host disease. It is also being studied in the treatment of some types of cancer. Jakafi blocks a protein called JAK, which may help keep abnormal blood cells or cancer cells from growing. It may also lower the body’s immune response. Jakafi is a type of tyrosine kinase inhibitor. Also called ruxolitinib phosphate.

    Explore Medical Terms from Medical Dictionary by A-Z Letter:


    20000+ Medical & Health Terms for Doctors, students & patients from a medical dictionary. Our experts define difficult medical & health language in easy-to-understand explanations of each and every medical term.

    Medical & Health Terms online medical dictionary provides quick & easy access to hard-to-spell and often misspelled medical & health definitions through an extensive alphabetical A- Z listing.


    DOCTOR’S MOST TRUSTED HEALTHCARE PLATFORM

    10M+

    Patients

    22000+

    Doctors

    20000+

    Hospitals/Labs

    Drlogy®
    The Power To Health

    Copyright © 2025 Drlogy. All rights reserved.

    menu_book

    Dictionary

    sort_by_alpha

    Abbreviation

    share

    Share